A health-tracking system you can swallow
The concept of swallowing microchip-embedded pills that are activated by stomach acid to transmit data isn't entirely new. But it could go from concept to market quite quickly, predicts Swiss firm Novartis.
In January, Novartis committed to spending $24 million on the smart pill technology developed by Redwood, Calif.-based Proteus Biomedical. This week, the company projects that it will seek regulatory approval--at least in Europe--within 18 months.
"We hope within the next 18 months to have something that we will be able to submit to the regulators," global head of development Trevor Mundel told the … Read more